Penumbra PEN - 옵션 체인 | ADVFN

다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

Penumbra Inc (PEN)

277.69

-8.69

(-3.03%)

마감 07 3월 6:00AM

277.69

0.00

(0.00%)

시간외 거래: 7:30AM

PEN 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	81.00	85.90	0.00	83.45	0.00	0.00 %	0	0	-
200.00	76.10	80.00	0.00	78.05	0.00	0.00 %	0	0	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	56.50	60.20	0.00	58.35	0.00	0.00 %	0	0	-
230.00	46.60	50.50	0.00	48.55	0.00	0.00 %	0	0	-
240.00	37.00	40.60	0.00	38.80	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	19.00	22.60	44.20	20.80	0.00	0.00 %	0	2	-
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	1.10	3.30	2.20	2.20	-1.40	-38.89 %	2	729	07/03/2025
310.00	0.55	2.50	2.60	1.525	0.00	0.00 %	0	37	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.05	1.65	0.56	0.85	0.00	0.00 %	0	2,487	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
200.00	1.12	2.20	1.12	1.66	0.00	0.00 %	0	2	-
210.00	0.00	2.25	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.42	2.40	0.42	1.41	0.00	0.00 %	0	7	-
230.00	0.10	1.80	3.80	0.95	0.00	0.00 %	0	6	-
240.00	0.55	2.30	6.90	1.425	0.00	0.00 %	0	4	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	1.50	4.40	2.00	2.95	0.00	0.00 %	0	11	-
270.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
280.00	8.60	10.80	5.70	9.70	0.00	0.00 %	0	14	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	22.40	25.40	16.70	23.90	0.00	0.00 %	0	15	-
310.00	31.20	35.00	0.00	33.10	0.00	0.00 %	0	0	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	50.50	54.50	0.00	52.50	0.00	0.00 %	0	0	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
370.00	90.00	94.90	0.00	92.45	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PSTVPlus Therapeutics Inc	US$ 1.46 (317.14%)	359.59M
AGMHAGM Group Holdings Inc	US$ 0.213 (108.21%)	694.71M
LZMHLZ Technology Holdings Ltd	US$ 9.79 (33.56%)	590.5k
TNXPTonix Pharmaceuticals Holding Corporation	US$ 14.62 (33.39%)	16.07M
GVVisionary Holdings Inc	US$ 4.89 (32.34%)	135.24M
BLNEEastside Distilling Inc	US$ 0.7846 (-89.40%)	12.25k
ACONAclarion Inc	US$ 1.5501 (-77.86%)	51.53M
ELABPMGC Holdings Inc	US$ 0.7132 (-42.02%)	1.51M
SNBRSleep Number Corporation	US$ 7.49 (-41.89%)	4.56M
CCLDCareCloud Inc	US$ 2.0904 (-33.00%)	1.23M
AGMHAGM Group Holdings Inc	US$ 0.213 (108.21%)	690.72M
PSTVPlus Therapeutics Inc	US$ 1.46 (317.14%)	357.55M
NVDANVIDIA Corporation	US$ 110.57 (-5.74%)	314.56M
GVVisionary Holdings Inc	US$ 4.89 (32.34%)	134.05M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.75 (-11.38%)	131.89M

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 년 전

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 년 전

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10 년 전

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10 년 전

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10 년 전

IPO should be out soon.
no symbol yet.

Vontobel Financial Produ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관